News I want to share. 10-3-2026

























Trans Athletes: Last Week Tonight with John Oliver (HBO)

John Oliver discusses why trans athletes seem to be at the center of U.S. politics right now, the nuances around competition and safety, where the conversation could be headed, and what The Rock would do in a barre class. 

 

ObGyn: Is Science Anti-Transgender?

Another great video for trans information from a medical provider.  She talks about a lot of subject trans people face and have to deal with along with offering advice and support.   Hugs

For the duration of Pride, half of all merch revenue will be donated to the BLACK TRANS COALITION. Get yourself an inclusive science shirt. TRANS PRIDE: https://teespring.com/dark-trans-prid… RAINBOW PRIDE: https://teespring.com/new-pride-scien… More Options: https://teespring.com/stores/mamadoct…

Science Proves There are More than Two Human Sexes

I have posted this before and it is a great source of easy to understand science on sex.  The old idea is that there are only two sexes, male and female so if it dangles your a boy / male and if it doesn’t your a girl / female.  But as always medical science like most other sciences progressed and more data and facts became clear.  Sex is not binary instead it is a spectrum.   So for those that say you can’t change your sex, actually sex determination by genital inspection is incomplete and our sex is determined by far more than your genitalia.  I once posted an article by a biologist that did a full chemical work up on a woman who had given birth to three children.  That woman was happily female but her genetic markers and chemical make up had her slightly male.  I have read of men with full working penises whose genetic makeup marks them as female.  Life is far more diverse and wonderful than we once understood.  Hug


 

We’re taught that chromosomes define biological sex: XX = female, and XY = male. However it’s not quite that straightforward. Hank Green hosts as we explain how science proves that biological sex is a spectrum.

Interview with Iranian President

Iranian President Masoud Pezeshkian speaks with Face the Nation’s Margaret Brennan about the war with the U.S., his country’s latest offer to open the Strait of Hormuz, the supreme leader’s condition and more.

This interview is increadable.  The Irain sounds so reasonable and smart.  While our president is issuing threats of anilation and other esculating things, this guy shows all Iran wants is to be respected and allowed to have their own government.  The US and Israel have been on a campaign for decades to assassinate their leaders and testify as if they have the right to do so.  Yet this guy asks, What if someone did that to you—killed your leaders, your scientists?  The interviewer had no response.  Due to dogma and propaganda, the people in the US hold the Iranian government to a standard we do not hold any other country to.  All because Israel wants to dominate them.  I found the ambassador and the president on a different network to be very sincere and forthright while our own people lie and make up reasons why we must keep attacking them.  Look this guy mentions that while they were in honest open talks, and negotiations, Israel and the US bombed the negotiating team.  How is that even thought to be OK?  The US gets them to the table to talk and then blows up the table.  And it is all to support Israel.  Where is Israel’s support for this war now?  They started it and then sat back and let the US taxpayer pay the entire cost. Take from that what you will.   Hugs

News I want to share. 9-14-2026





















Tim Miller Confronts Neera Tanden Over Her Hasan Derangement Syndrome

The Progressive Movement Needs Ed Markey To Win In Massachusetts

 

Political news I want to share. 8-26-2026

‘Graveyard for Grants’: NIH Is Holding Up Medical Research Funding

https://www.notus.org/health-science/nih-holding-up-medical-research-funding-status-19

Hundreds of grants, including for maternal health, contraceptives and drug abuse, are in limbo, subject to political reviews.

Trump Jay Battacharya

The Trump administration is implementing more political oversight of grants. Alex Brandon/AP

It used to be that once a National Institutes of Health grant award hit “status 19,” the money was about to go out the door.

That’s not the case anymore. The Trump administration has enacted an unprecedented political review process, pushing hundreds of awards into limbo. Status 19 — an administrative code describing awards with senior leadership sign-off — is being used as the holding cell.

Current and former career staff say this extra review by senior leaders is occurring after grants have undergone peer review, been approved by multiple offices in NIH, and screened for red-flag words around race, gender or other behavioral and social sciences. The extra political reviews are required not only for newly funded grants but also for annual payment installments for previously awarded projects.

As a result, some grants are lingering in status 19 for weeks or even months, gumming up the works as grant officers try to get awards out the door ahead of the new fiscal year starting in October. Flagged grants reviewed by NOTUS had to do with maternal health, contraceptive use, aging, dementia and opioid abuse.

“The notion that Francis Collins or Mike Lauer would ever have reviewed individual grants like this is so beyond the realm of comprehension,” a senior career staffer said, referring to the former directors of NIH and its Office of Extramural Research. “It’s laughable to me.”

A second senior NIH official called status 19 a “graveyard for grants.” The NIH staffers were granted anonymity because they weren’t authorized to speak to the media.

As one of the largest grant funders in the federal government, NIH’s process is a prime example of how the Trump administration is implementing more political oversight of grants across a wide swath of agencies, even as its efforts to formalize those reviews face pushback.

Senate Republicans voted to temporarily block a White House regulation to formalize political review, which has already led to delays in posting and awarding grants at the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, the Department of Interior and other agencies.

Researchers, patient advocates and biotech companies are outraged by the proposed regulation, which the White House is seeking to implement by Oct. 1 but could be blocked until December if the House also approves a delay.

Senior NIH leaders sent around a new agency review flowchart in May outlining additional steps once an award hits status 19. The flowchart, viewed by NOTUS, mandates a review by the NIH Office of Extramural Research (OER) and an HHS counselor before grantees are given a notice of award. There are no political appointees at OER, but its director reports to NIH Director and Trump appointee Jay Bhattacharya.

As a result of the extra reviews, the number of grants sitting for weeks in status 19 have surged. Around 8% of new grant awards are sitting in status 19 for anywhere from two to seven weeks, according to internal data shared with NOTUS.

In past years, around 11% of first-time awards had been released to the recipients within a week. This year, it’s 2%.

The delays are even more pronounced for annual payment installments for ongoing grants. The vast majority previously left status 19 within three days; now it takes 53 days to get 90% of payments out the door.

Lauer, who served as NIH’s extramural research director from 2015 to February 2025, said he couldn’t recall a time when a political appointee — including the NIH director — halted awarding of a research grant after it had gone through the review and approval process.

“Status 19 was not something I thought about,” Lauer told NOTUS.

NIH career staff stress that by the time grant awards reach status 19, they have been through dozens of editing and review steps. They’ve undergone peer review and a second look by an advisory council. Grant officers have gone through a checklist, including confirming that women and racial minorities have been appropriately included, something required by statute.

In grants reviewed by NOTUS, HHS or EOR staff flagged words including “diverse,” “equity,” “structural” and “underrepresented” and asked for clarification about what the researchers meant by them. In one project, a staffer wrote that the word “structural” could include concepts that are inconsistent with NIH priorities.

They asked for more clarification in projects that focused on health disparities or racial groups. Officials wrote that focusing on specific racial groups required more justification. In one project that expressed support for scholars and researchers from a variety of backgrounds, an official responded that the language could raise legal concerns if interpreted as targeting people based on demographics.

In multiple flagged grants, officials expressed concerns that they weren’t worth funding because their only practical use might be to support the writing of new laws.

HHS spokeswoman Emily Hilliard disputed the notion that status 19 is being used to hold up grants under extra political reviews. She said grants can remain in status 19 for five to 10 days while they are given final review by the Office of Extramural Research.

“There is no political appointee review stage in the NIH grant review process,” Hilliard said in a statement. “OER’s review is a longstanding part of NIH’s grant review process.”

Lauer said releasing grant money might face occasional delays, but it was almost always because Congress had failed to pass a budget for NIH, leading to uncertainty about how much total grant funding would be available.

Trump appointees are also conducting extra layers of review to the notices posted by the government to let researchers know money is available for specific projects or programs. Researchers say they’ve seen more delays in posting those notices — another obstacle in getting grant funding out the door.

“It’s this black box of HHS review,” said Colleen Kelley, an associate dean for research at Emory University.